Nos dernières actualités

Atalante X, Wandercraft’s Self-Balancing Rehabilitation Exoskeleton, Receives ARCSA Clearance in Ecuador, Advancing Latin American Expansion

Wandercraft and Good Shepherd Rehabilitation Launch Collaboration for Eve, Wandercraft’s Personal Exoskeleton Projected to be Available Later This Summer.

Wandercraft Names National Seating & Mobility the Exclusive CRT Distribution Partner for Eve™ Personal Exoskeleton

When a foreign robot enters a European factory, it's our secrets that leave with it

Wandercraft Announces Availability of Atalante X in Australia Following Therapeutic Goods Administration (TGA) Approval

Air Force Veteran Uses Advanced Exoskeleton Training to Reclaim Upright Movement – 12 Years After Paralysis

From Clinic to Home: What We Learned at APTA CSM and World Health Expo

How Human Should a Humanoid Be? A Builder’s Perspective

Wandercraft Appoints Permobil CEO Chuck Witkowski to Board of Directors, Signaling a New Phase of Growth and Global Commercialization

First Patient Enrolled in Groundbreaking Clinical Trial of Early Mobilization in ICU Using Wandercraft’s Self-Balancing Exoskeleton

Wandercraft and SAPA Announce Deployment Partnership in Industrial Manufacturing, Cementing Europe’s Emerging Championship in the Humanoids Race

Wandercraft Gains Second FDA Indication Extension for Atalante X in Less Than Two Years, Extending Advanced Robotic Rehabilitation for More Patients with Severe Mobility Loss

Wandercraft Selected for the Inaugural Physical AI Fellowship Powered by AWS, NVIDIA, and MassRobotics

Wandercraft Announces CE Mark Expansion for Atalante X, Advancing Care for Patients with Tetraplegia and Other Complex Neurological Conditions

Moody Neurorehabilitation Institute Acquires Wandercraft’s Atalante X to Transform Care for Complex Patients

Introducing Calvin-40

Wandercraft Celebrates Opening of “Walk in New York” to Restore Upright Mobility for People with Mobility Disabilities

New study shows how Atalante X fits seamlessly into rehabilitation workflows

Wandercraft Personal Exoskeleton Achieves 100% Success Rate for Key Usability Tasks in New Study

Announcing Walk in New York by Wandercraft: Where Movement is Medicine

Wandercraft Announces First Participants Enrolled in Clinical Trial of the World’s First Self-Balancing Personal Exoskeleton

Wandercraft Takes the Field at NVIDIA’s “Super Bowl of AI”

Wandercraft’s Self-Balancing Exoskeleton Wins 2025 SXSW Innovation Award for Artificial Intelligence

Wandercraft’s Atalante X Enables Significant Gait Improvements in Post-Stroke Gait Rehabilitation in New Case Study

Wandercraft Launches Pivotal Clinical Trial of Its Groundbreaking Personal Exoskeleton

Wandercraft’s Personal Exoskeleton Honored as SXSW Innovation Award Finalist

Wandercraft Publishes First Case Study of Exoskeleton Use in Long-Term Care

Wandercraft Recognized by NVIDIA at CES 2025

Wandercraft Showcases First Self-Balancing Exoskeleton at 2024 Summer Olympic & Paralympic Torch Relay

Medical robotics company Wandercraft receives €25 million in financing from EIB to advance self-balancing exoskeletal technology

Wandercraft's self-balancing exoskeleton receives second FDA clearance in less than a year, now indicated for rehabilitation in patients with spinal cord injury

Wandercraft unveils a groundbreaking innovation, its self-stabilizing Personal Exoskeleton, at an exclusive event in New York

Wandercraft, a pioneer in walking robotics, is exhibiting for the first time at the ARAB HEALTH trade show in Dubai in 2020 booth Z2L15

Wandercraft has been honored with the “Robot of the year” award

Wandercraft equips Henri-Mondor with an Atalante exoskeleton thanks to the #ProtègeTonSoignant collective.

How Robots Can Help People With Disabilities Walk Again #CNBC

On making millions of different people walk again #ICRA2020

Wandercraft launches new generation exoskeleton investigation

Wandercraft has launched its mobility exoskeleton Atalante X in the United States in partnership with the Kessler Foundation.